Smith & Nephew plc (LON:SN) has been given a consensus rating of “Hold” by the nine ratings firms that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and two have issued a buy recommendation on the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is GBX 1,452.83 ($18.98).
SN has been the topic of a number of research reports. HSBC lowered Smith & Nephew to a “hold” rating and boosted their price objective for the stock from GBX 1,400 ($18.29) to GBX 1,500 ($19.60) in a research report on Tuesday, October 16th. Deutsche Bank restated a “sell” rating on shares of Smith & Nephew in a research report on Friday, October 5th. UBS Group restated a “neutral” rating on shares of Smith & Nephew in a research report on Friday, October 26th. Finally, Berenberg Bank boosted their price objective on Smith & Nephew from GBX 1,370 ($17.90) to GBX 1,475 ($19.27) and gave the stock a “hold” rating in a research report on Friday, November 2nd.
Shares of SN traded up GBX 54.50 ($0.71) during midday trading on Monday, hitting GBX 1,475 ($19.27). The company’s stock had a trading volume of 4,386,355 shares, compared to its average volume of 3,250,000. Smith & Nephew has a one year low of GBX 1,173 ($15.33) and a one year high of GBX 1,442 ($18.84).
About Smith & Nephew
Smith & Nephew plc designs, develops, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.
Recommended Story: What are catch-up contributions?
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.